Skip to Content

Notice

Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 50948

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before October 27, 2014.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. Request for hearings should be sent to: Drug Enforcement Administration, Attention: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, and dispensers of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (“Deputy Assistant Administrator”) pursuant to section 7 of 28 CFR pt. 0, subpt. R, App.

In accordance with 21 CFR 1301.33(a), this is notice that on June 6, 2014, Chemtos, LLC, 14101 W. Highway 290, Building 2000B, Austin, Texas 78737-9331, applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Controlled substanceSchedule
Amphetamine (1100)II
Methamphetamine (1105)II
Lisdexamfetamine (1205)II
Methylphenidate (1724)II
Nabilone (7379)II
Phenylacetone (8501)II
Cocaine (9041)II
Codeine (9050)II
Etorphine HCI (9059)II
Dihydrocodeine (9120)II
Oxycodone (9143)II
Hydromorphone (9150)II
Ecgonine (9180)II
Ethylmorphine (9190)II
Hydrocodone (9193)II
Levomethorphan (9210)II
Levorphanol (9220)II
Isomethadone (9226)II
Meperidine (9230)II
Meperidine intermediate-A (9232)II
Meperidine intermediate-B (9233)II
Meperidine intermediate-C (9234)II
Methadone (9250)II
Methadone intermediate (9254)II
Morphine (9300)II
Thebaine (9333)II
Dihydroetorphine (9334)II
Levo-alphacetylmethadol (9648)II
Oxymorphone (9652)II
Racemethorphan (9732)II
Racemorphan (9733)II

The company plans to manufacture small quantities of the listed controlled substances in bulk for distribution to its customers for use as reference standards.

Start Signature

Dated: August 19, 2014.

Joseph T. Rannazzisi,

Deputy Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2014-20195 Filed 8-25-14; 8:45 am]

BILLING CODE 4410-09-P